Objective: To discuss one double-eyelid surgery which is conformed to the anatomy characteristics of the asian upper eyelid. Methods: A total of 162 cases were performed blepharoplasty for double eyelids, who aged 19 to 33 years with average 24.22±3.05 years, including 28 men and 134 women. Double eyelid line was designed according to the overall characteristics of eyebrows and eyes of beauty seekers combined with aesthetic standards. The surgery was performed to restore the anatomical characteristics of natural double eyelids as far as possible. Results: The double eyelid surgery was designed and performed in 162 cases based on this method. All the patients underwent suture removal 7 days after operation, none of them had postoperative infection, and 15 patients had the bruising during the first week. After symptomatic treatment, the bruising had gone in 1 month. All the cases were followed up for more than six months postoperatively, and eight cases presented shallow double eyelid and the satisfactory results were achieved after the second operation of small incision. Conclusions The double-eyelid line should be designed individually before operation and the surgery done according to the natural characteristics of Asian upper eyelid. It will get coherent double eyelid without obvious scar or depression at resection margin, with high satisfactory rate.

Objective To investigate both the short-and long-term effect of botulinum toxin type A (BTXA) injection on hypertrophic ache scar.Methods A total of 26 patients with acne scar received BTXA injection of within 100 units.The effect was evaluated using the ECCA grading scale before treatment and during clinic re-visit,which based on history of acne scar and number of scar area.The short-and long-term effect was recorded.The average follow-up period was 39.23 months.All results were evaluated by SPSS 21.0.ANOVA was used to evaluate average value and standard deviation of ECCA grading scale.Kaplan-Meier survival curve was used to evaluate relapse-free period,and Pearson test was used to detect relevant factors of relapse-free period.Results The BTXA injection showed significant positive long-term effect on inflammatory or hypertrophic acne scar.The average ECCA grading scale was 103.460 ±36.872 before treatment,79.620 ±37.146 at 6 months after treatment,63.160 ±24.049 at 12 months after treatment,47.500 ±4.629 at 18 months after treatment,and 50.000 ± 0.000 at 24 months after treatment,showing significant differences between any of two groups (P ＜ 0.01).Average relapsefree period was 28.354 ± 1.775 months.Relapse-free period was related to ECCA grading scale pre treatment and injection times (P ＜ 0.01);meanwhile,dose of BTXA and length of disease all had statistical significance (P ＜ 0.05);however,age and gender had no statistical significance (P ＞ 0.05).Conclusions The BTXA injection can relieve inflammation and improve scar texture in patients with hypertrophic acne scar in both the short-and long-term follow-up.

Objective To investigate both the short-and long-term effect of botulinum toxin type A (BTXA) injection on hypertrophic ache scar.Methods A total of 26 patients with acne scar received BTXA injection of within 100 units.The effect was evaluated using the ECCA grading scale before treatment and during clinic re-visit,which based on history of acne scar and number of scar area.The short-and long-term effect was recorded.The average follow-up period was 39.23 months.All results were evaluated by SPSS 21.0.ANOVA was used to evaluate average value and standard deviation of ECCA grading scale.Kaplan-Meier survival curve was used to evaluate relapse-free period,and Pearson test was used to detect relevant factors of relapse-free period.Results The BTXA injection showed significant positive long-term effect on inflammatory or hypertrophic acne scar.The average ECCA grading scale was 103.460 ±36.872 before treatment,79.620 ±37.146 at 6 months after treatment,63.160 ±24.049 at 12 months after treatment,47.500 ±4.629 at 18 months after treatment,and 50.000 ± 0.000 at 24 months after treatment,showing significant differences between any of two groups (P ＜ 0.01).Average relapsefree period was 28.354 ± 1.775 months.Relapse-free period was related to ECCA grading scale pre treatment and injection times (P ＜ 0.01);meanwhile,dose of BTXA and length of disease all had statistical significance (P ＜ 0.05);however,age and gender had no statistical significance (P ＞ 0.05).Conclusions The BTXA injection can relieve inflammation and improve scar texture in patients with hypertrophic acne scar in both the short-and long-term follow-up.